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Results from a Bench Marking Survey
on Supporting Chemical Synthesis
and Structural Elucidation
in the Pharmaceutical Industry
David A. Peake and Bradley L. Ackermann
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, USAThis communication provides a summary of thePharmaceutical Interest Group workshop held onTuesday, May 25, 2004, during the 52nd ASMS
Conference on Mass Spectrometry and Allied Topics in
Nashville, TN. The focus of the workshop was “Sup-
porting Chemical Synthesis and Structural Elucidation
in the Pharmaceutical Industry.” Building on the suc-
cess of the 2003 workshop in Montreal [1], the emphasis
of the 2004 meeting was on pharmaceutical benchmark-
ing, facilitated by a survey conducted prior to the
conference.
The topic of chemical synthesis was selected for
several reasons. First and foremost, chemical synthesis
is a subject of immense importance to the pharmaceu-
tical industry and is an area that has benefited greatly
from ongoing advances in mass spectrometry. More-
over, to our knowledge, a benchmark analysis has not
been reported previously on this important issue. Fi-
nally, it has been our observation that MS practices
related to chemical synthesis have continuously
evolved to meet the ever-changing demands presented
by this central part of our business. Accordingly, this
workshop provided a unique opportunity to discuss
current topics as well as future trends.
The topic of chemical synthesis invoked lively dis-
cussion from the 75 to 100 society members in atten-
dance, many of whom offered personal insight during
the discussion. The workshop agenda included presen-
tations by three invited speakers, prior to a report of the
survey results, the disclosure of which is the subject of
the present communication. A copy of the results may
be obtained from the corresponding author, David
Peake (peake_david@lilly.com). Inquiries about the
ASMS Pharmaceutical Interest Group should be di-
rected to the current chair, Brad Ackermann
(ackermann_bradley_l@lilly.com).
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In the past 10 years, rapid technological advances in
coupling liquid chromatography and mass spectrome-
try (LC/MS) have led to significant growth in the
introduction of bench-top quadrupole, ion trap and
time-of-flight (TOF) LC/MS instrumentation. The dra-
matic advances in less expensive bench-top instruments
have obviated the need to dedicate research instru-
ments for performing routine analyses such as nominal
molecular weight determination of synthetic com-
pounds for evaluation as potential drugs. The impact on
routine chemical synthesis support by development of
open access (OA) software integrated with LC/MS
systems has been reported in the literature [2– 6].
In the mid to late 1990s, the use of OA LC/MS was
established as a tool for synthetic chemists, but most
companies still maintained dedicated central labs for
compound characterization and structure elucidation.
Although LC/MS instrumentation was available from
several vendors, OA software often lacked flexibility
and instrumentation suffered from robustness issues.
Integration of peripheral LC, auto-sampler and UV
(ultraviolet) and other detectors within the MS data
system was poor since control was implemented via
serial communications port or parallel GPIB (general
purpose interface bus) devices and contact closure
timing.
The business of drug discovery was also changing
during this time from synthesis of one compound at a
time to the adoption of combinatorial or parallel syn-
thesis chemistry strategies [7] often yielding mixtures of
compounds requiring identification and purification.
This led to an increased demand for high throughput
flow injection analysis (HTP FIA) and LC/MS, in addi-
tion to the development of mass-guided LC/MS sys-
tems for automated purification. As the amount of data
produced from OA and HTP LC/MS systems grew, it
led some groups to develop informatics strategies for
automated data interpretation [8].
In the past five years, many improvements in per-
sonal computer (PC) hardware and operating systems
have occurred, as well as the widespread use of Ether-
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1394) communication protocols with analytical instru-
ments. A new generation of compact bench-top mass
spectrometers with rugged API (atmospheric pressure
ionization) sources and higher sensitivity have made
LC/MS technology more accessible to chemists and
chromatographers, without the need for extensive pre-
vious experience with mass spectrometry. In addition,
exact mass measurements are now routinely performed
via LC/TOF MS instruments [9] providing chemists
with the elemental composition of newly synthesized
organic compounds.
Based on the technology trends noted above, 4 topic
areas related to chemical synthesis were identified includ-
ing (1) open access MS monitoring of sample purity and
nominal mass measurement, (2) auto-purification via
mass-guided LC/MS, (3) structure confirmation/elucida-
tion, and (4) HTP LC/MS of compound libraries.
2004 Pharma Interest Group Workshop:
Supporting Chemical Synthesis
To facilitate discussion and information sharing on the
current state of chemical synthesis support via mass
spectrometry, three speakers were invited to stimulate
discussions on topics related to the theme of the work-
shop. The first speaker, Ken Lewis, Ph.D. (Eli Lilly),
discussed chromatographic considerations for perform-
ing high throughput LC/MS coupled with UV, evapo-
rative light scattering (ELS) and chemiluminescence
nitrogen (CLN) detection, and gave tips for maximizing
peak capacity. An interesting discussion ensued after
his presentation concerning the future role of ultra high
pressure (UP) LC in synthesis support. The consensus
was that UPLC technology is worth pursuing; however,
use of currently available LC detectors may lead to
severe band broadening of the very narrow peaks
obtained with ultra high pressure LC.
The second speaker, Justin Stroh, Ph.D., (Pfizer),
discussed his experience with open access medicinal
chemistry support at Groton. Justin gave examples
highlighting the somewhat different objectives of
medicinal chemists and analytical scientists. Justin
described his operation that consists of 24 instru-
ments with three different configurations at nine
different locations. The key to success is robustness of
the entire system with built in redundancy to cover
both capacity issues and instrument downtime. The
need for more stable software for open access was
highlighted including improved functionality, data
processing and communication with HPLC and other
components.
Larry Mallis, Ph.D. (Wyeth) gave the third presenta-
tion on the use of a 4-way multiplexed (MUX) API
source coupled with TOF for exact m/z determination.
This subject sparked an extended dialogue on the
appropriate use of exact mass in the pharmaceutical
industry. Based on the survey results, demand for exactmass measurement has steadily increased as the work-
load has shifted from magnetic sector to TOF and
Fourier Transform (FT) MS instruments. It was clear
from the discussion that a large driver for exact mass
data continues to be the support of publication for
organic synthesis. Additional discussion focused on the
limitations of current software for automated exact
mass determination, including the inability to estimate
precision. There is much interest in making exact mass
available via open access, but there is a general concern
for the lack of quality control (QC) functionality in the
software to ensure accurate results without any opera-
tor intervention.
The remainder of the workshop was a presentation
by David Peake, Ph.D. (Lilly) devoted to results of a
benchmarking survey conducted just prior to the
ASMS Conference. The results of the survey are
presented below, followed by a brief analysis of the
data.
Questionnaire on Supporting Chemical
Synthesis and Structure Elucidation
The survey was comprised of five sections with seven to
eight questions covering (1) background information
and four distinct topics including (2) open access LC/
MS, (3) automated purification via LC/MS, (4) organic
structure elucidation, and (5) HTP LC/MS analysis of
libraries or large compound collections. The primary
group targeted was analytical experts having direct
experience with small molecule synthesis support or
structure elucidation, in either drug discovery, process
or development support roles. Several questionnaires
were sent within the US yielding a total of 21 responses.
Of these, 85 percent of the total responses came from
“pharma” and represented 12 different major pharma-
ceutical companies with drug discovery, development,
and manufacturing capabilities. The percentage of re-
sponses from “biotechnology” (small companies fo-
cused on discovery of biomolecular therapeutics) or
“academic” institutions was 15 percent. When the re-
spondents were asked about the size of their facility, 52
percent indicated they support 100 to 200 or more
customers and the remaining 48 percent of survey
participants indicated support for 20 to 100 customers.
The questionnaire is reproduced below with the
instructions in italics and responses to each question
listed in parentheses. Unless otherwise noted, values in
parentheses are % of total responses, with more than
one response being possible for each multiple-choice
question. For some multiple-choice questions, the re-
spondents were asked to estimate the percentage of use
for each response. For questions with estimated usage,
the average % usage was multiplied by the fraction of
the total responses and normalized to give the reported
% total usage.
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QUESTION 1






How many customers does your facility support?
Choose one answer.
(a) 0 to 20 (0%)
(b) 20 to 50 (24%)
(c) 50 to 100 (24%)
(d) 100 to 200 (14%)
(e) 200 (38%)
QUESTION 3
What are the geographical locations for supported
groups? Choose all answers that apply.
(a) Single buildings (24%)
(b) Multiple buildings (71%)
(c) One site (19%)
(d) Multiple sites (33%)
QUESTION 4
How is your instrumentation deployed?
Choose all answers that apply.
(a) End-user supported, remote labs (29%)
(b) Analytical group supported, remote labs (52%)
(c) Analytical group supported, central labs (95%)
QUESTION 5
What types of data are shared with customers?
Choose all answers that apply.
(a) Purity and nominal MW (100%)
(b) Concentration or estimated quantity (52%)
(c) Chiral purity and MW information (43%)
(d) Exact mass or structural information (76%)
(e) Other: Impurity or degradant identification (5%)
QUESTION 6
How are data distributed to end-users?
Choose all answers that apply.
(a) PDF (portable document format) (33%)
(b) HTML (hypertext markup language) (14%)
(c) Browser application (52%)
(d) Custom software (52%)
(e) Hardcopy (33%)
(f) Other: e-mail, NuGenesis (15%)QUESTION 7
What new MS technologies do you need?
Choose all answers that apply.
(a) Exact mass measurement (38%)
(b) High resolution FTMS (25%)
(c) Parallel LC/MS (6%)
(d) Electrospray ionization (ESI) chip (31%)
(e) Open access exact mass (13%)
(f) Fast gas chromatography (GC/MS) (6%)
(g) Ion trap MS/MS (6%)
QUESTION 8
Which chromatographic technologies are you consider-
ing? Choose all answers that apply.
(a) Supercritical fluid chromatography (SFC) (56%)
(b) Ultra-high pressure (UP) LC (50%)
(c) 2-Dimensional LC (13%)
(d) Parallel LC (25%)
(e) Capillary electrophoresis (CE) (6%)
(f) Turbulent flow (6%)
(h) Analytical to preparative LC/MS (6%)
SECTION 2. Open Access MS
QUESTION 9
What types of open access instruments are used?
Choose all that apply and estimate % usage.
[Values in parentheses are normalized % total usage.]
(a) Quadrupole MS (96%)
(b) TOF MS (4%)
(c) Ion trap MS (0%)
QUESTION 10
What ionization choices are used?
Choose all that apply and estimate % usage.
[Values in parentheses are normalized % total usage.]
(a) Electrospray Ionization (ESI) (67%)
(b) Atmospheric pressure chemical ionization (APCI)
(26%)
(c) Alternating ESI/APCI (1%)
(d) Electron ionization (EI)/CI /Desorption-CI (6%)




Which MS vendors are preferred for open access?
Choose all that apply and estimate % usage.
[Values in parentheses are normalized % total usage.]
(a) ABI (Sciex) (9%)
(b) Agilent (HP) (19%)
(c) Shimadzu (2%)
(d) Thermo (Finnigan) (11%)
(e) Waters (Micromass) (59%)
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What types of chromatographic/inlet methods are
available? Choose all that apply and estimate % usage.
[Values in parentheses are normalized % total usage.]
(a) Flow injection analysis (FIA) (31%)
(b) Reversed phase HPLC (64%)
(c) Normal phase HPLC (1%)
(d) Capillary GC (4%)
QUESTION 13
What is the average usage per open access system?
Choose the metrics that best apply.
[Values in parentheses are the average of all responses.]
(a) Users/system (27)
(b) Samples/month/system (1800)
(c) 96-Well plates/day/system (1.0)
QUESTION 14
What are the issues with your open access systems?
Rank order from 1  low priority to 5  high priority.
[Values in parentheses are the average rank order.]
(a) Reliability of chromatographic system (2.4)
(b) Reliability of MS hardware and software (3.7)
(c) Functionality (hardware and software) (2.9)
(d) Vendor service issues (response time) (3.1)
(e) Data processing issues (2.4)
QUESTION 15
What is the biggest bottleneck in open access?
Choose one answer.
(a) Sample capacity (6%)
(b) Chromatographic speed (41%)
(c) Data processing/report viewing (35%)
(d) Data archival/retrieval (29%)
(e) Vendor service response time (6%)
QUESTION 16
How do end users view their data?
Choose preferred method.
(a) Browser application (37%)
(b) E-Mail report (11%)
(c) Web link (26%)
(d) Custom software (11%)
(e) Hardcopy (37%)
(f) NuGenesis (5%)
SECTION 3. LC/MS-Guided Purification
QUESTION 17
What types of instrumentation are used for purifica-
tion? Choose all that apply and estimate % usage.
[Values in parentheses are normalized % total usage.](a) LC/MS (77%)
(b) Supercritical fluid chromatography (SFC) MS
(2%)
(c) LC UV (14%)
(d) SFC UV (7%)
QUESTION 18
What ionization methods do you use?
Choose all that apply and estimate % usage.
[Values in parentheses are normalized % total usage.]
(a) Electrospray ionization (ESI) (77%)
(b) Atmospheric pressure chemical ionization (APCI)
(23%)
QUESTION 19
What are typical sample sizes for purification?
Choose all that apply and estimate % usage.
[Values in parentheses are normalized % total usage.]
(a) 0–25 mg (34%)
(b) 25–50 mg (35%)
(c) 50–100 mg (13%)
(d) 100–500 mg (14%)
(e) 500 mg (4%)
QUESTION 20
What types of chromatographic methods are used?
Choose all that apply and estimate % usage.
[Values in parentheses are normalized % total usage.]
(a) Reversed phase (87%)
(b) Normal phase (2%)
(c) Chiral (3%)
(d) Supercritical fluid (8%)
QUESTION 21
What triggers are used to start fraction collection?
Choose all that apply and estimate % usage.





What is your throughput per purification system?
Samples purified per day.
[Values in parentheses are the average of all responses.]
(a) Average–Samples/day/system (89)
QUESTION 23
How do end users view their data?
Choose preferred method.
(a) Browser application (80%)
(b) Hardcopy (20%)
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Confirmation/Elucidation
QUESTION 24
What types of MS instruments are used?
Choose all that apply and estimate % usage.
[Values in parentheses are normalized % total usage.]
(a) Quadrupole (37%)
(b) TOF MS (23%)
(c) Ion trap (12%)
(d) Triple quadrupole (12%)
(e) TOF MS/MS (6%)
(f) Magnetic sector (3%)
(f) FTMS (7%)
QUESTION 25
What ionization choices do you use for structure con-
firmation? Choose all that apply and estimate % usage.
[Values in parentheses are normalized % total usage.]
(a) ESI (electrospray ionization) (67%)
(b) APCI (atmospheric pressure chemical ionization)
(17%)
(c) Electron ionization (EI)/CI /desorption-CI (9%)
(d) LSIMS (liquid secondary ion mass spectrometry)
(1%)
(e) MALDI (matrix-assisted laser desorption/ioniza-
tion) (3%)
(f) APPI (atmospheric pressure photo ionization) (3%)
QUESTION 26
Which MS vendors are preferred for structure confir-
mation? Choose all that apply and estimate % usage.
[Values in parentheses are normalized % total usage.]
(a) ABI (Sciex) (14%)
(b) Agilent (9%)
(c) Bruker (6%)
(d) Thermo (Finnigan) (12%)
(e) Waters (Micromass) (58%)
(e) JEOL (1%)
QUESTION 27
Which types of MS analyses are available?
Choose all that apply and estimate % usage.
[Values in parentheses are normalized % total usage.]
(a) Exact mass (26%)





How many samples are run or problems solved per
system? Choose the metrics that best apply.
[Values in parentheses are the average responses.](a) Samples/day/system (18)
(b) Samples/month/system (950)
(c) Problems solved/month/system (24)
(d) Total samples/month (8400)
QUESTION 29
What are the issues most important to you?
Rank order from 1  low priority to 4  high priority.
[Values in parentheses are the average rank order.]
(a) Reliability of MS hardware and software (2.9)
(b) Reliability of data processing (2.4)
(c) Data reporting and viewing (2.8)
(d) Data storage and retrieval (2.5)
QUESTION 30
How do end users view their data?
Choose preferred method.
(a) Browser application (35%)
(b) E-mailed report (12%)
(c) Web link (0%)
(d) Custom software (24%)
(e) Hardcopy (53%)
SECTION 5. High Throughput Analysis
of Compound Collections
QUESTION 31
What types of MS instruments are used?
Choose all that apply and estimate % usage.
[Values in parentheses are normalized % total usage.]
(a) Quadrupole (79%)
(b) TOF MS (21%)
QUESTION 32
What ionization methods are used?
Choose all that apply and estimate % usage.
[Values in parentheses are normalized % total usage.]
(a) ESI (electrospray ionization) (84%)
(b) APCI (atmospheric pressure chemical ionization)
(14%)
(c) Alternating ESI/APCI (2%)
QUESTION 33
Which MS vendors are preferred for HTP analysis?
Choose all that apply and estimate % usage.
[Values in parentheses are normalized % total usage.]
(a) ABI (Sciex) (7%)
(b) Agilent (18%)
(c) Thermo (Finnigan) (5%)
(d) Waters (Micromass) (69%)
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What types of HTP chromatographic methods are used?
Choose all that apply and estimate % usage.
[Values in parentheses are normalized % total usage.]
(a) Reversed phase (87%)
(b) Parallel LC (8%)
(c) Supercritical fluid chromatography (SFC) (5%)
QUESTION 35
What is the average throughput per system?
Choose the metrics that best apply.
[Values in parentheses are the average responses; aver-
age is 5700 samples/month.]
(a) Samples/day/system (460)
(b) Samples/month/system (3100)
(c) 96-Well plates/month/system (3)
QUESTION 36
Which detectors are used to estimate sample purity or
concentration? Choose all that apply and estimate % usage.
[Values in parentheses are normalized % total usage.]
(a) UV (single wavelength) (30%)
(b) PDA UV (Photodiode array) (37%)
(c) Evaporative light scattering (ELS) (26%)
(d) Chemiluminescence nitrogen (CLN) (6%)
QUESTION 37
How are end reports distributed to the end user?
Choose preferred method.
(a) Browser application (33%)
(b) Web link (5%)
(c) Custom software/database (43%)
(d) Hardcopy (14%)
(d) PDF (portable document format) (6%)
Discussion
The responses to the survey captured a number of
trends, which are discussed below. Although the re-
sponses received reflect a broad coverage of the phar-
maceutical industry, no claims can be made regarding
the statistical validity of the results reported. Using the
survey results, it was possible to construct a profile for
the “average” synthesis support group within the phar-
maceutical industry.
Profile of an “Average” Synthesis
Support Group
• The group supports 100 to 200 customers spread
among multiple buildings or sites.
• It has a central analytical lab as well as additional
remote labs.• Labs contain a mix of LC/MS instruments and ven-
dors using both ESI and APCI.
• Open access involves a mix of FIA and reversed-
phase LC/MS running 24/7.
• PDA UV and ELS are the primary tools used for
estimating purity.
• There are an average of 25 chemists supported per
open access system.
• Each open access instrument runs an average of 80
samples per day.
• Purification typically involves sample sizes ranging
from 50 to 200 mg.
• Mass-guided fraction collection outweighs UV-
guided purification by 2:1.
• HTP LC/MS typically accommodate three plates per
day or 5000 samples per month.
• A variety of instruments are available for exact mass
measurement and structure determination including
quadrupole-TOF, triple quadrupole, ion trap, and FT
mass spectrometers.
General Observations
The growth of OA LC/MS as a routine tool for obtain-
ing molecular weight and purity information on syn-
thetic compounds has been steady over the past 10
years. The use of auto-purification has enabled auto-
mation of one of a synthetic chemist’s most tedious
tasks. The lack of functionality with OA software was
mentioned as a major limitation. Since many of the
older open access systems lack intelligent communica-
tion between all of the various modules, improper
handling of peripheral communication errors is one of
the problems that contribute to overall reliability issues.
HTP LC/MS analyses require careful matching of the
chromatographic setup with several different detectors
to get a better estimate of purity. There is no magic
bullet when it comes to a universal detector. Informatics
is needed to track all of the data generated with
multiple LC/MS systems requires customized software
and databases in order to process, store and retrieve the
data. Automated data analysis is still needed to cor-
rectly assign molecular weights and to provide confi-
dence in the data being generated, since human inter-
vention is not possible for QC of large compound
collections.
Exact mass measurement is now routine with TOF
MS instruments and has been demonstrated to be
rugged enough for open access use. Instruments with
exact mass capabilities account for 40% of the structure
confirmation/elucidation analyses reported in the sur-
vey. The reporting of exact mass data without confi-
dence limits is a practice the ASMS does not recom-
mend [10, 11]. At a minimum, one needs to be able to
estimate precision of individual measurements by
tracking the long-term instrument performance via au-
tomated analysis of known QC samples on a regular
basis.
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Results from a survey on supporting chemical synthe-
sis, conducted on behalf of the ASMS Pharmaceutical
Interest Group, are presented which provide an assess-
ment of current practices used in the pharmaceutical
industry. The purpose of the present communication is
to disseminate this information, in accordance with a
key objective of the Pharmaceutical Interest Group to
act as a conduit for benchmark analysis on topics of
pharmaceutical interest. Based on the level of interac-
tion achieved at the 2004 workshop, a similar format
will be used in 2005.
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